Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Bupropion in the treatment of depression in Parkinson's disease.

Załuska M, Dyduch A.

Int Psychogeriatr. 2011 Mar;23(2):325-7. doi: 10.1017/S1041610210001687.

PMID:
20809995
2.

[Successful treatment of depression in a Parkinson disease patient with bupropion].

Leentjens AF, Verhey FR, Vreeling FW.

Ned Tijdschr Geneeskd. 2000 Nov 4;144(45):2157-9. Dutch.

PMID:
11086491
3.

Bupropion as the treatment of choice in depression associated with Parkinson's disease and it's various treatments.

Raskin S, Durst R.

Med Hypotheses. 2010 Dec;75(6):544-6. doi: 10.1016/j.mehy.2010.07.024. Epub 2010 Aug 12.

PMID:
20708340
4.
5.

Reversal of atypical depression, sleepiness, and REM-sleep propensity in narcolepsy with bupropion.

Rye DB, Dihenia B, Bliwise DL.

Depress Anxiety. 1998;7(2):92-5.

PMID:
9614600
6.

The bupropion-related subcortical changes in a depression patient.

Lai CH.

Aust N Z J Psychiatry. 2015 Dec;49(12):1224. doi: 10.1177/0004867415580819. Epub 2015 Apr 1. No abstract available.

PMID:
25834136
7.

Motor changes during sertraline treatment in depressed patients with Parkinson's disease*.

Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, Gironell A, García-Sánchez C, Martínez-Corral M.

Eur J Neurol. 2008 Sep;15(9):953-9. doi: 10.1111/j.1468-1331.2008.02218.x. Epub 2008 Jul 14.

PMID:
18637826
8.

Paroxetine/bupropion combination treatment for refractory depression.

Marshall RD, Liebowitz MR.

J Clin Psychopharmacol. 1996 Feb;16(1):80-1. No abstract available.

PMID:
8834426
9.

A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.

Coleman CC, King BR, Bolden-Watson C, Book MJ, Segraves RT, Richard N, Ascher J, Batey S, Jamerson B, Metz A.

Clin Ther. 2001 Jul;23(7):1040-58.

PMID:
11519769
10.

Bupropion: efficacy and safety in the treatment of depression.

Saiz Ruiz J, Gibert J, Gutiérrez Fraile M, Bobes J, Vallejo J, Iglesias C, Iriarte V.

Actas Esp Psiquiatr. 2011;39 Suppl 1:1-25. Epub 2011 Jan 1. Review. English, Spanish. No abstract available.

PMID:
22983817
11.

Effect of bupropion on depression symptoms in a smoking cessation clinical trial.

Lerman C, Niaura R, Collins BN, Wileyto P, Audrain-McGovern J, Pinto A, Hawk L, Epstein LH.

Psychol Addict Behav. 2004 Dec;18(4):362-6.

PMID:
15631608
12.

Treatment options for depression and psychosis in Parkinson's disease.

Poewe W, Seppi K.

J Neurol. 2001 Sep;248 Suppl 3:III12-21. Review.

PMID:
11697683
13.

Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression.

Cox LS, Patten CA, Niaura RS, Decker PA, Rigotti N, Sachs DP, Buist AS, Hurt RD.

J Gen Intern Med. 2004 Aug;19(8):828-34.

14.

The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review.

Leentjens AF.

Drugs. 2011 Feb 12;71(3):273-86. doi: 10.2165/11585380-000000000-00000. Review.

PMID:
21319866
15.

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Barone P, Poewe W, Albrecht S, Debieuvre C, Massey D, Rascol O, Tolosa E, Weintraub D.

Lancet Neurol. 2010 Jun;9(6):573-80. doi: 10.1016/S1474-4422(10)70106-X. Epub 2010 May 7.

PMID:
20452823
16.

Bupropion for treatment of interferon-induced depression.

Malek-Ahmadi P, Ghandour E.

Ann Pharmacother. 2004 Jul-Aug;38(7-8):1202-5. Epub 2004 May 18.

PMID:
15150377
17.

Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.

Weihs KL, Settle EC Jr, Batey SR, Houser TL, Donahue RM, Ascher JA.

J Clin Psychiatry. 2000 Mar;61(3):196-202.

PMID:
10817105
18.

A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants.

DeBattista C, Solvason HB, Poirier J, Kendrick E, Schatzberg AF.

J Clin Psychopharmacol. 2003 Feb;23(1):27-30.

PMID:
12544372
19.

A bupropion smoking cessation clinical trial for cancer patients.

Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, Ridge JA, Langer C, Miyamoto C, Wileyto EP, Leone F.

Cancer Causes Control. 2010 Jun;21(6):811-20. doi: 10.1007/s10552-010-9507-8. Epub 2010 Jan 20.

PMID:
20087643
20.

Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism.

Hayford KE, Patten CA, Rummans TA, Schroeder DR, Offord KP, Croghan IT, Glover ED, Sachs DP, Hurt RD.

Br J Psychiatry. 1999 Feb;174:173-8.

PMID:
10211174

Supplemental Content

Support Center